219 related articles for article (PubMed ID: 25424807)
1. Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention.
Dhalla S; Poole G
Hum Vaccin Immunother; 2014; 10(7):1974-84. PubMed ID: 25424807
[TBL] [Abstract][Full Text] [Related]
2. Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US.
Priddy FH; Cheng AC; Salazar LF; Frew PM
Int J STD AIDS; 2006 Feb; 17(2):99-102. PubMed ID: 16464270
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic status and HIV vaccine preparedness studies in North America.
Dhalla S; Poole G
Vaccine; 2015 May; 33(22):2536-45. PubMed ID: 25820065
[TBL] [Abstract][Full Text] [Related]
4. Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents.
Giocos G; Kagee A; Swartz L
AIDS Behav; 2008 Nov; 12(6):842-51. PubMed ID: 17668313
[TBL] [Abstract][Full Text] [Related]
5. Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials.
Doshi M; Avery L; Kaddu RP; Gichuhi M; Gakii G; du Plessis E; Dutta S; Khan S; Kimani J; Lorway RR
BMC Public Health; 2017 May; 17(1):469. PubMed ID: 28521748
[TBL] [Abstract][Full Text] [Related]
6. Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.
Djomand G; Katzman J; di Tommaso D; Hudgens MG; Counts GW; Koblin BA; Sullivan PS
Public Health Rep; 2005; 120(5):543-8. PubMed ID: 16224987
[TBL] [Abstract][Full Text] [Related]
7. Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study.
Connochie D; Tingler RC; Bauermeister JA
Vaccine; 2019 Oct; 37(43):6494-6499. PubMed ID: 31522806
[TBL] [Abstract][Full Text] [Related]
8. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users.
Golub ET; Purvis LA; Sapun M; Safaeian M; Beyrer C; Vlahov D; Strathdee SA
AIDS Behav; 2005 Sep; 9(3):301-9. PubMed ID: 16088366
[TBL] [Abstract][Full Text] [Related]
9. Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.
O'Connell JM; Hogg RS; Chan K; Strathdee SA; McLean N; Martindale SL; Willoughby B; Remis R
J Acquir Immune Defic Syndr; 2002 Dec; 31(5):521-8. PubMed ID: 12473841
[TBL] [Abstract][Full Text] [Related]
10. Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: a survey conducted among adolescents in Soweto, South Africa.
Otwombe KN; Sikkema KJ; Dietrich J; de Bruyn G; van der Watt M; Gray GE
J Acquir Immune Defic Syndr; 2011 Oct; 58(2):211-8. PubMed ID: 21765362
[TBL] [Abstract][Full Text] [Related]
11. Willingness to participate in HIV vaccine trials: the impact of trial attributes.
Newman PA; Duan N; Lee SJ; Rudy E; Seiden D; Kakinami L; Cunningham W
Prev Med; 2007 Jun; 44(6):554-7. PubMed ID: 17275895
[TBL] [Abstract][Full Text] [Related]
12. Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users.
Dhalla S; Poole G; Singer J; Patrick DM; Wood E; Kerr T
Vaccine; 2010 Feb; 28(7):1663-7. PubMed ID: 20044049
[TBL] [Abstract][Full Text] [Related]
13. Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study.
Mayanja Y; Abaasa A; Namale G; Price MA; Kamali A
BMC Public Health; 2020 Nov; 20(1):1789. PubMed ID: 33239018
[TBL] [Abstract][Full Text] [Related]
14. Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials.
Etcheverry MF; Evans JL; Sanchez E; Mendez-Arancibia E; Meroño M; Gatell JM; Page K; Joseph J
Hum Vaccin Immunother; 2013 Feb; 9(2):420-9. PubMed ID: 23291931
[TBL] [Abstract][Full Text] [Related]
15. An update on human immunodeficiency virus vaccine preparedness studies.
Dhalla S
J Med Microbiol; 2015 Jul; 64(7):731-738. PubMed ID: 25908608
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India.
Suhadev M; Nyamathi AM; Swaminathan S; Suresh A; Venkatesan P
AIDS Res Hum Retroviruses; 2009 Feb; 25(2):217-24. PubMed ID: 19239362
[TBL] [Abstract][Full Text] [Related]
17. Does message framing predict willingness to participate in a hypothetical HIV vaccine trial: an application of Prospect Theory.
Evangeli M; Kafaar Z; Kagee A; Swartz L; Bullemor-Day P
AIDS Care; 2013; 25(7):910-4. PubMed ID: 23216424
[TBL] [Abstract][Full Text] [Related]
18. Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies.
Dhalla S; Poole G
AIDS Care; 2011 Nov; 23(11):1430-47. PubMed ID: 21722022
[TBL] [Abstract][Full Text] [Related]
19. Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India.
Newman PA; Chakrapani V; Weaver J; Shunmugam M; Rubincam C
Vaccine; 2014 Oct; 32(44):5854-61. PubMed ID: 25173475
[TBL] [Abstract][Full Text] [Related]
20. Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men.
Li Q; Luo F; Zhou Z; Li S; Liu Y; Li D; Shi W; Raymond HF; Ruan Y; Shao Y
Vaccine; 2010 Jun; 28(29):4638-43. PubMed ID: 20452428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
